Standard Biotools (LAB) Return on Sales (2010 - 2026)

Standard Biotools (LAB) has 17 years of Return on Sales data on file, last reported at 0.07% in Q1 2026.

• On a quarterly basis, Return on Sales rose 7.0% year-over-year to 0.07% in Q1 2026; TTM through Mar 2026 was 0.01%, a 2.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.07%, up from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for LAB reached as high as 0.07% in Q1 2026 and fell as low as 0.03% in Q2 2022.
• Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.01% in 2023.
• Across the five-year window, Return on Sales fell 5 bps in 2023 and advanced 7 bps in 2026, its largest moves.
• Year by year, Return on Sales stood at 0.06% in 2022, then plunged by 91 bps to 0.01% in 2023, then tumbled by 156 bps to 0.0% in 2024, then surged by 181 bps to 0.0% in 2025, then soared by 2863 bps to 0.07% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.07% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.